Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis - a Multi-centre, Randomised, Double-masked, Parallel-group, Phase IV Comparison
Conditions
Interventions
Posiformin 2 %, bibrocathol
Placebo Comparator
Locations
1
Ukraine
Kharkov District Clinical Hospital
Kharkiv, Ukraine
Start Date
February 1, 2009
Primary Completion Date
July 1, 2009
Completion Date
August 1, 2009
Last Updated
May 20, 2011
NCT07166172
NCT04603222
NCT07451678
NCT03043911
NCT04606199
NCT05374746
Lead Sponsor
Ursapharm Arzneimittel GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions